ID   IVD_HUMAN               Reviewed;         423 AA.
AC   P26440; B2RCV5; B3KVI7; J3KR54; Q53XZ9; Q96AF6;
DT   01-AUG-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1992, sequence version 1.
DT   10-MAY-2017, entry version 184.
DE   RecName: Full=Isovaleryl-CoA dehydrogenase, mitochondrial;
DE            Short=IVD;
DE            EC=1.3.8.4;
DE   Flags: Precursor;
GN   Name=IVD;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2318964; DOI=10.1172/JCI114536;
RA   Matsubara Y., Ito M., Glassberg R., Satyabhama S., Ikeda Y.,
RA   Tanaka K.;
RT   "Nucleotide sequence of messenger RNA encoding human isovaleryl-
RT   coenzyme A dehydrogenase and its expression in isovaleric acidemia
RT   fibroblasts.";
RL   J. Clin. Invest. 85:1058-1064(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10677295; DOI=10.1086/302751;
RA   Vockley J., Rogan P.K., Anderson B.D., Willard J., Seelan R.S.,
RA   Smith D.I., Liu W.;
RT   "Exon skipping in IVD RNA processing in isovaleric acidemia caused by
RT   point mutations in the coding region of the IVD gene.";
RL   Am. J. Hum. Genet. 66:356-367(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Pericardium, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 381-423.
RX   PubMed=8468053; DOI=10.1006/geno.1993.1111;
RA   Parimoo B., Tanaka K.;
RT   "Structural organization of the human isovaleryl-CoA dehydrogenase
RT   gene.";
RL   Genomics 15:582-590(1993).
RN   [9]
RP   PROTEIN SEQUENCE OF N-TERMINUS.
RX   PubMed=1310317;
RA   Vockley J., Nagao M., Parimoo B., Tanaka K.;
RT   "The variant human isovaleryl-CoA dehydrogenase gene responsible for
RT   type II isovaleric acidemia determines an RNA splicing error, leading
RT   to the deletion of the entire second coding exon and the production of
RT   a truncated precursor protein that interacts poorly with mitochondrial
RT   import receptors.";
RL   J. Biol. Chem. 267:2494-2501(1992).
RN   [10]
RP   PROTEIN SEQUENCE OF 30-47.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [11]
RP   ACTIVE SITE, AND MUTAGENESIS OF GLU-283.
RX   PubMed=7640268; DOI=10.1021/bi00032a007;
RA   Mohsen A.W., Vockley J.;
RT   "Identification of the active site catalytic residue in human
RT   isovaleryl-CoA dehydrogenase.";
RL   Biochemistry 34:10146-10152(1995).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-75, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   CLEAVAGE OF TRANSIT PEPTIDE [LARGE SCALE ANALYSIS] AFTER ALA-29, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 30-423 IN COMPLEX WITH FAD
RP   AND SUBSTRATE ANALOG, AND COFACTOR.
RX   PubMed=9214289; DOI=10.1021/bi970422u;
RA   Tiffany K.A., Roberts D.L., Wang M., Paschke R., Mohsen A.W.,
RA   Vockley J., Kim J.-J.P.;
RT   "Structure of human isovaleryl-CoA dehydrogenase at 2.6-A resolution:
RT   structural basis for substrate specificity.";
RL   Biochemistry 36:8455-8464(1997).
RN   [17]
RP   VARIANTS IVA PRO-42 AND VAL-199.
RX   PubMed=2063866;
RA   Vockley J., Parimoo B., Tanaka K.;
RT   "Molecular characterization of four different classes of mutations in
RT   the isovaleryl-CoA dehydrogenase gene responsible for isovaleric
RT   acidemia.";
RL   Am. J. Hum. Genet. 49:147-157(1991).
RN   [18]
RP   VARIANTS IVA PRO-50; ASN-69; VAL-311; ARG-357; ALA-371; CYS-392 AND
RP   LEU-411.
RX   PubMed=9665741; DOI=10.1021/bi973096r;
RA   Mohsen A.-W.A., Anderson B.D., Volchenboum S.L., Battaile K.P.,
RA   Tiffany K.A., Roberts D.L., Kim J.-J.P., Vockley J.;
RT   "Characterization of molecular defects in isovaleryl-CoA dehydrogenase
RT   in patients with isovaleric acidemia.";
RL   Biochemistry 37:10325-10335(1998).
RN   [19]
RP   VARIANTS IVA GLY-94; ARG-120; PRO-276 AND CYS-400.
RX   PubMed=22004070; DOI=10.1111/j.1442-200X.2011.03488.x;
RA   Vatanavicharn N., Liammongkolkul S., Sakamoto O.,
RA   Sathienkijkanchai A., Wasant P.;
RT   "Phenotypic and mutation spectrums of Thai patients with isovaleric
RT   acidemia.";
RL   Pediatr. Int. 53:990-994(2011).
RN   [20]
RP   VARIANT IVA ARG-120.
RX   PubMed=22350545; DOI=10.1007/s10545-012-9457-2;
RA   Dercksen M., Duran M., Ijlst L., Mienie L.J., Reinecke C.J.,
RA   Ruiter J.P., Waterham H.R., Wanders R.J.;
RT   "Clinical variability of isovaleric acidemia in a genetically
RT   homogeneous population.";
RL   J. Inherit. Metab. Dis. 35:1021-1029(2012).
RN   [21]
RP   VARIANT IVA MET-196.
RX   PubMed=23587913; DOI=10.1016/j.gene.2013.03.139;
RA   Bei F., Sun J.H., Yu Y.G., Jia J., Zheng Z.J., Fu Q.H., Cai W.;
RT   "Two novel isovaleryl-CoA dehydrogenase gene mutations in a Chinese
RT   infant.";
RL   Gene 524:396-400(2013).
CC   -!- CATALYTIC ACTIVITY: Isovaleryl-CoA + electron-transfer
CC       flavoprotein = 3-methylcrotonyl-CoA + reduced electron-transfer
CC       flavoprotein.
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:9214289};
CC   -!- PATHWAY: Amino-acid degradation; L-leucine degradation; (S)-3-
CC       hydroxy-3-methylglutaryl-CoA from 3-isovaleryl-CoA: step 1/3.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:9214289}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P26440-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P26440-2; Sequence=VSP_045193;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Isovaleric acidemia (IVA) [MIM:243500]: A metabolic
CC       disorder characterized by retarded psychomotor development, a
CC       peculiar odor resembling sweaty feet, an aversion to dietary
CC       protein, and pernicious vomiting, leading to acidosis and coma.
CC       The acute neonatal form leads to massive metabolic acidosis from
CC       the first days of life and rapid death.
CC       {ECO:0000269|PubMed:2063866, ECO:0000269|PubMed:22004070,
CC       ECO:0000269|PubMed:22350545, ECO:0000269|PubMed:23587913,
CC       ECO:0000269|PubMed:9665741}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the acyl-CoA dehydrogenase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAG53799.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=EAW92413.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=EAW92414.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=EAW92415.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M34192; AAA52711.1; -; mRNA.
DR   EMBL; AF191218; AAF20182.1; -; Genomic_DNA.
DR   EMBL; AF191214; AAF20182.1; JOINED; Genomic_DNA.
DR   EMBL; AF191215; AAF20182.1; JOINED; Genomic_DNA.
DR   EMBL; AF191216; AAF20182.1; JOINED; Genomic_DNA.
DR   EMBL; AF191217; AAF20182.1; JOINED; Genomic_DNA.
DR   EMBL; BT007145; AAP35809.1; -; mRNA.
DR   EMBL; AK122922; BAG53799.1; ALT_INIT; mRNA.
DR   EMBL; AK315296; BAG37702.1; -; mRNA.
DR   EMBL; AC013356; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471125; EAW92413.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CH471125; EAW92414.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CH471125; EAW92415.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; BC017202; AAH17202.1; -; mRNA.
DR   EMBL; AF038318; AAB92584.1; -; Genomic_DNA.
DR   PIR; A37033; A37033.
DR   RefSeq; NP_001152980.1; NM_001159508.1.
DR   RefSeq; NP_002216.2; NM_002225.3.
DR   UniGene; Hs.513646; -.
DR   PDB; 1IVH; X-ray; 2.60 A; A/B/C/D=30-423.
DR   PDBsum; 1IVH; -.
DR   ProteinModelPortal; P26440; -.
DR   SMR; P26440; -.
DR   BioGrid; 109916; 10.
DR   IntAct; P26440; 2.
DR   STRING; 9606.ENSP00000418397; -.
DR   DrugBank; DB04036; Coenzyme a Persulfide.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   SwissLipids; SLP:000000936; -.
DR   iPTMnet; P26440; -.
DR   PhosphoSitePlus; P26440; -.
DR   SwissPalm; P26440; -.
DR   BioMuta; IVD; -.
DR   DMDM; 125051; -.
DR   REPRODUCTION-2DPAGE; IPI00645805; -.
DR   UCD-2DPAGE; P26440; -.
DR   EPD; P26440; -.
DR   MaxQB; P26440; -.
DR   PaxDb; P26440; -.
DR   PeptideAtlas; P26440; -.
DR   PRIDE; P26440; -.
DR   DNASU; 3712; -.
DR   Ensembl; ENST00000479013; ENSP00000417990; ENSG00000128928.
DR   GeneID; 3712; -.
DR   KEGG; hsa:3712; -.
DR   UCSC; uc001zlq.3; human. [P26440-1]
DR   CTD; 3712; -.
DR   DisGeNET; 3712; -.
DR   GeneCards; IVD; -.
DR   HGNC; HGNC:6186; IVD.
DR   HPA; HPA041391; -.
DR   HPA; HPA044250; -.
DR   MalaCards; IVD; -.
DR   MIM; 243500; phenotype.
DR   MIM; 607036; gene.
DR   neXtProt; NX_P26440; -.
DR   Orphanet; 33; Isovaleric acidemia.
DR   PharmGKB; PA29984; -.
DR   eggNOG; KOG0141; Eukaryota.
DR   eggNOG; ENOG410XNMY; LUCA.
DR   HOGENOM; HOG000131659; -.
DR   HOVERGEN; HBG000224; -.
DR   InParanoid; P26440; -.
DR   KO; K00253; -.
DR   PhylomeDB; P26440; -.
DR   TreeFam; TF105050; -.
DR   BRENDA; 1.3.8.4; 2681.
DR   Reactome; R-HSA-70895; Branched-chain amino acid catabolism.
DR   SABIO-RK; P26440; -.
DR   UniPathway; UPA00363; UER00860.
DR   ChiTaRS; IVD; human.
DR   EvolutionaryTrace; P26440; -.
DR   GenomeRNAi; 3712; -.
DR   PRO; PR:P26440; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000128928; -.
DR   CleanEx; HS_IVD; -.
DR   ExpressionAtlas; P26440; baseline and differential.
DR   Genevisible; P26440; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; ISS:BHF-UCL.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0008470; F:isovaleryl-CoA dehydrogenase activity; EXP:Reactome.
DR   GO; GO:0009083; P:branched-chain amino acid catabolic process; TAS:Reactome.
DR   GO; GO:0006552; P:leucine catabolic process; ISS:BHF-UCL.
DR   CDD; cd01156; IVD; 1.
DR   Gene3D; 1.10.540.10; -; 1.
DR   InterPro; IPR006089; Acyl-CoA_DH_CS.
DR   InterPro; IPR006091; Acyl-CoA_Oxase/DH_cen-dom.
DR   InterPro; IPR009075; AcylCo_DH/oxidase_C.
DR   InterPro; IPR013786; AcylCoA_DH/ox_N.
DR   InterPro; IPR009100; AcylCoA_DH/oxidase_NM_dom.
DR   InterPro; IPR034183; IVD.
DR   Pfam; PF00441; Acyl-CoA_dh_1; 1.
DR   Pfam; PF02770; Acyl-CoA_dh_M; 1.
DR   Pfam; PF02771; Acyl-CoA_dh_N; 1.
DR   SUPFAM; SSF47203; SSF47203; 1.
DR   SUPFAM; SSF56645; SSF56645; 1.
DR   PROSITE; PS00072; ACYL_COA_DH_1; 1.
DR   PROSITE; PS00073; ACYL_COA_DH_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Direct protein sequencing; Disease mutation; FAD; Flavoprotein;
KW   Mitochondrion; Oxidoreductase; Reference proteome; Transit peptide.
FT   TRANSIT       1     29       Mitochondrion.
FT                                {ECO:0000244|PubMed:25944712,
FT                                ECO:0000269|PubMed:12665801,
FT                                ECO:0000269|PubMed:1310317}.
FT   CHAIN        30    423       Isovaleryl-CoA dehydrogenase,
FT                                mitochondrial.
FT                                /FTId=PRO_0000000531.
FT   NP_BIND     162    171       FAD. {ECO:0000269|PubMed:9214289}.
FT   NP_BIND     195    197       FAD. {ECO:0000269|PubMed:9214289}.
FT   NP_BIND     377    381       FAD. {ECO:0000269|PubMed:9214289}.
FT   NP_BIND     406    408       FAD. {ECO:0000269|PubMed:9214289}.
FT   REGION      219    220       Substrate binding.
FT   REGION      281    284       Substrate binding.
FT   REGION      404    405       Substrate binding.
FT   ACT_SITE    283    283       Proton acceptor.
FT                                {ECO:0000269|PubMed:7640268}.
FT   BINDING     171    171       Substrate; via carbonyl oxygen.
FT   BINDING     274    274       Substrate.
FT   BINDING     309    309       FAD. {ECO:0000269|PubMed:9214289}.
FT   BINDING     320    320       FAD. {ECO:0000269|PubMed:9214289}.
FT   MOD_RES      55     55       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9JHI5}.
FT   MOD_RES      55     55       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9JHI5}.
FT   MOD_RES      64     64       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9JHI5}.
FT   MOD_RES      64     64       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9JHI5}.
FT   MOD_RES      75     75       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      75     75       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9JHI5}.
FT   MOD_RES     238    238       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9JHI5}.
FT   MOD_RES     259    259       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9JHI5}.
FT   MOD_RES     259    259       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9JHI5}.
FT   MOD_RES     315    315       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9JHI5}.
FT   VAR_SEQ      49     78       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045193.
FT   VARIANT      42     42       L -> P (in IVA).
FT                                {ECO:0000269|PubMed:2063866}.
FT                                /FTId=VAR_000423.
FT   VARIANT      50     50       R -> P (in IVA).
FT                                {ECO:0000269|PubMed:9665741}.
FT                                /FTId=VAR_015960.
FT   VARIANT      69     69       D -> N (in IVA).
FT                                {ECO:0000269|PubMed:9665741}.
FT                                /FTId=VAR_015961.
FT   VARIANT      94     94       A -> G (in IVA).
FT                                {ECO:0000269|PubMed:22004070}.
FT                                /FTId=VAR_070061.
FT   VARIANT     120    120       G -> R (in IVA; dbSNP:rs142761835).
FT                                {ECO:0000269|PubMed:22004070,
FT                                ECO:0000269|PubMed:22350545}.
FT                                /FTId=VAR_070062.
FT   VARIANT     196    196       I -> M (in IVA).
FT                                {ECO:0000269|PubMed:23587913}.
FT                                /FTId=VAR_070063.
FT   VARIANT     199    199       G -> V (in IVA).
FT                                {ECO:0000269|PubMed:2063866}.
FT                                /FTId=VAR_000424.
FT   VARIANT     276    276       L -> P (in IVA).
FT                                {ECO:0000269|PubMed:22004070}.
FT                                /FTId=VAR_070064.
FT   VARIANT     311    311       A -> V (in IVA; dbSNP:rs28940889).
FT                                {ECO:0000269|PubMed:9665741}.
FT                                /FTId=VAR_015962.
FT   VARIANT     357    357       C -> R (in IVA).
FT                                {ECO:0000269|PubMed:9665741}.
FT                                /FTId=VAR_015963.
FT   VARIANT     371    371       V -> A (in IVA).
FT                                {ECO:0000269|PubMed:9665741}.
FT                                /FTId=VAR_015964.
FT   VARIANT     392    392       R -> C (in IVA).
FT                                {ECO:0000269|PubMed:9665741}.
FT                                /FTId=VAR_015965.
FT   VARIANT     400    400       Y -> C (in IVA).
FT                                {ECO:0000269|PubMed:22004070}.
FT                                /FTId=VAR_070065.
FT   VARIANT     411    411       R -> L (in IVA).
FT                                {ECO:0000269|PubMed:9665741}.
FT                                /FTId=VAR_015966.
FT   MUTAGEN     283    283       E->D: Residual activity.
FT                                {ECO:0000269|PubMed:7640268}.
FT   MUTAGEN     283    283       E->G,Q: Loss of activity.
FT                                {ECO:0000269|PubMed:7640268}.
FT   CONFLICT     10     10       W -> C (in Ref. 3; AAP35809 and 7;
FT                                AAH17202). {ECO:0000305}.
FT   HELIX        38     40       {ECO:0000244|PDB:1IVH}.
FT   HELIX        44     60       {ECO:0000244|PDB:1IVH}.
FT   TURN         61     64       {ECO:0000244|PDB:1IVH}.
FT   HELIX        65     71       {ECO:0000244|PDB:1IVH}.
FT   HELIX        77     87       {ECO:0000244|PDB:1IVH}.
FT   TURN         90     93       {ECO:0000244|PDB:1IVH}.
FT   HELIX        96     98       {ECO:0000244|PDB:1IVH}.
FT   HELIX       105    118       {ECO:0000244|PDB:1IVH}.
FT   HELIX       120    130       {ECO:0000244|PDB:1IVH}.
FT   TURN        131    133       {ECO:0000244|PDB:1IVH}.
FT   HELIX       134    140       {ECO:0000244|PDB:1IVH}.
FT   HELIX       143    154       {ECO:0000244|PDB:1IVH}.
FT   STRAND      160    163       {ECO:0000244|PDB:1IVH}.
FT   STRAND      169    172       {ECO:0000244|PDB:1IVH}.
FT   HELIX       173    175       {ECO:0000244|PDB:1IVH}.
FT   STRAND      179    182       {ECO:0000244|PDB:1IVH}.
FT   STRAND      184    197       {ECO:0000244|PDB:1IVH}.
FT   HELIX       199    201       {ECO:0000244|PDB:1IVH}.
FT   STRAND      203    211       {ECO:0000244|PDB:1IVH}.
FT   HELIX       218    221       {ECO:0000244|PDB:1IVH}.
FT   STRAND      222    228       {ECO:0000244|PDB:1IVH}.
FT   STRAND      234    236       {ECO:0000244|PDB:1IVH}.
FT   STRAND      242    244       {ECO:0000244|PDB:1IVH}.
FT   STRAND      250    261       {ECO:0000244|PDB:1IVH}.
FT   HELIX       262    264       {ECO:0000244|PDB:1IVH}.
FT   STRAND      265    267       {ECO:0000244|PDB:1IVH}.
FT   HELIX       272    287       {ECO:0000244|PDB:1IVH}.
FT   HELIX       289    306       {ECO:0000244|PDB:1IVH}.
FT   HELIX       316    318       {ECO:0000244|PDB:1IVH}.
FT   HELIX       320    348       {ECO:0000244|PDB:1IVH}.
FT   HELIX       354    379       {ECO:0000244|PDB:1IVH}.
FT   HELIX       380    384       {ECO:0000244|PDB:1IVH}.
FT   HELIX       390    399       {ECO:0000244|PDB:1IVH}.
FT   TURN        400    404       {ECO:0000244|PDB:1IVH}.
FT   HELIX       407    419       {ECO:0000244|PDB:1IVH}.
SQ   SEQUENCE   423 AA;  46319 MW;  121AF14C7F1FA13D CRC64;
     MATATRLLGW RVASWRLRPP LAGFVSQRAH SLLPVDDAIN GLSEEQRQLR QTMAKFLQEH
     LAPKAQEIDR SNEFKNLREF WKQLGNLGVL GITAPVQYGG SGLGYLEHVL VMEEISRASG
     AVGLSYGAHS NLCINQLVRN GNEAQKEKYL PKLISGEYIG ALAMSEPNAG SDVVSMKLKA
     EKKGNHYILN GNKFWITNGP DADVLIVYAK TDLAAVPASR GITAFIVEKG MPGFSTSKKL
     DKLGMRGSNT CELIFEDCKI PAANILGHEN KGVYVLMSGL DLERLVLAGG PLGLMQAVLD
     HTIPYLHVRE AFGQKIGHFQ LMQGKMADMY TRLMACRQYV YNVAKACDEG HCTAKDCAGV
     ILYSAECATQ VALDGIQCFG GNGYINDFPM GRFLRDAKLY EIGAGTSEVR RLVIGRAFNA
     DFH
//
